FI933728A0 - Framstaellning och anvaendning av formalin-doedade e.coli-organismer som uttrycker kolonisationfaktorantigen (cfa) foer vaccinering mot tarminflammation/diarre foerorsakad av enterotoxigeniska e.coli bakterier i maenniskan - Google Patents

Framstaellning och anvaendning av formalin-doedade e.coli-organismer som uttrycker kolonisationfaktorantigen (cfa) foer vaccinering mot tarminflammation/diarre foerorsakad av enterotoxigeniska e.coli bakterier i maenniskan

Info

Publication number
FI933728A0
FI933728A0 FI933728A FI933728A FI933728A0 FI 933728 A0 FI933728 A0 FI 933728A0 FI 933728 A FI933728 A FI 933728A FI 933728 A FI933728 A FI 933728A FI 933728 A0 FI933728 A0 FI 933728A0
Authority
FI
Finland
Prior art keywords
coli
formalin
vaccinering
uttrycker
tarminflammation
Prior art date
Application number
FI933728A
Other languages
English (en)
Other versions
FI108775B (fi
FI933728A (fi
Inventor
Jan Holmgrem
Ann-Mari Svennerholm
Original Assignee
Holmgren Jan
Svennerholm Ann Mari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holmgren Jan, Svennerholm Ann Mari filed Critical Holmgren Jan
Publication of FI933728A0 publication Critical patent/FI933728A0/fi
Publication of FI933728A publication Critical patent/FI933728A/fi
Application granted granted Critical
Publication of FI108775B publication Critical patent/FI108775B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI933728A 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi FI108775B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9100556 1991-02-26
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
SE9200110 1992-02-25
PCT/SE1992/000110 WO1992014487A1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans

Publications (3)

Publication Number Publication Date
FI933728A0 true FI933728A0 (fi) 1993-08-25
FI933728A FI933728A (fi) 1993-10-25
FI108775B FI108775B (fi) 2002-03-28

Family

ID=20381987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933728A FI108775B (fi) 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi

Country Status (22)

Country Link
US (1) US6558678B1 (fi)
EP (1) EP0573527B1 (fi)
JP (1) JP3169608B2 (fi)
KR (1) KR100221452B1 (fi)
AT (1) ATE170755T1 (fi)
AU (1) AU663864B2 (fi)
BG (1) BG61683B1 (fi)
BR (1) BR9205677A (fi)
CA (1) CA2104877C (fi)
CZ (1) CZ281556B6 (fi)
DE (1) DE69226944T2 (fi)
DK (1) DK0573527T3 (fi)
ES (1) ES2123550T3 (fi)
FI (1) FI108775B (fi)
HU (1) HU213924B (fi)
NO (1) NO307867B1 (fi)
OA (1) OA09865A (fi)
RO (1) RO109819B1 (fi)
RU (1) RU2127121C1 (fi)
SE (1) SE9100556D0 (fi)
SK (1) SK280919B6 (fi)
WO (1) WO1992014487A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118758B1 (en) * 1997-01-24 2006-10-10 The United States Of America As Represented By The Secretary Of The Army Transformed bacteria producing CS6 antigens as vaccines
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria
US7404961B2 (en) 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
US7094883B1 (en) 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
SE515285C2 (sv) * 1998-12-18 2001-07-09 Sbl Vaccin Ab Oralt vaccin mot diarré
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
JP5100122B2 (ja) * 2003-10-31 2012-12-19 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 細菌の病原因子とそれらの使用
CN101378780A (zh) * 2006-02-01 2009-03-04 Sbl疫苗公司 重组细菌中的肠产毒性大肠杆菌定居因子(cf)抗原
JPWO2012157699A1 (ja) * 2011-05-18 2014-07-31 味の素株式会社 動物用免疫賦活剤、それを含む飼料及びその製造方法
US8926980B2 (en) 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
KR101940357B1 (ko) 2011-09-12 2019-01-18 스칸디나비안 바이오파마 홀딩 에이비 세포 표면 상 ｅｔｅｃ ｃｓ６ 항원 제시의 증가 방법 및 그것의 수득가능한 산물들
WO2013037397A1 (en) 2011-09-12 2013-03-21 Scandinavian Biopharma Holding Ab Vaccine for protection against etec induced diarrhea comprising dmlt.
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (fi) *
DE1208038B (de) * 1963-08-01 1965-12-30 Wellcome Found Verfahren zur Herstellung von Impfstoffen gegen Coli-Infektionen
GB1472624A (en) 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
DE3650065T2 (de) * 1985-07-31 1995-03-02 Univ Leland Stanford Junior Invasive Mikroorganismen.
FI76484C (fi) 1986-02-03 1988-11-10 Osmo Norvasto Kundstol.
JPS6399020A (ja) 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
WO1990002484A1 (en) * 1988-09-06 1990-03-22 Washington University Oral immunization by transgenic plants
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria

Also Published As

Publication number Publication date
BR9205677A (pt) 1994-05-17
HU213924B (en) 1997-11-28
CZ281556B6 (cs) 1996-11-13
BG61683B1 (bg) 1998-03-31
RO109819B1 (ro) 1995-06-30
SE9100556D0 (sv) 1991-02-26
ES2123550T3 (es) 1999-01-16
NO933037L (no) 1993-08-25
US6558678B1 (en) 2003-05-06
OA09865A (en) 1994-08-15
DK0573527T3 (da) 1999-06-07
HUT67198A (en) 1995-02-28
CA2104877A1 (en) 1992-08-27
WO1992014487A1 (en) 1992-09-03
HU9302410D0 (en) 1993-11-29
AU663864B2 (en) 1995-10-26
EP0573527A1 (en) 1993-12-15
DE69226944T2 (de) 1999-02-11
NO307867B1 (no) 2000-06-13
ATE170755T1 (de) 1998-09-15
NO933037D0 (no) 1993-08-25
CA2104877C (en) 2005-10-04
JPH06505730A (ja) 1994-06-30
EP0573527B1 (en) 1998-09-09
SK280919B6 (sk) 2000-09-12
CZ174293A3 (en) 1994-04-13
KR930703015A (ko) 1993-11-29
FI108775B (fi) 2002-03-28
JP3169608B2 (ja) 2001-05-28
KR100221452B1 (ko) 1999-09-15
BG98070A (bg) 1994-06-30
FI933728A (fi) 1993-10-25
RU2127121C1 (ru) 1999-03-10
AU1330892A (en) 1992-09-15
DE69226944D1 (de) 1998-10-15
SK91093A3 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
FI933728A (fi) Framstaellning och anvaendning av formalin-doedade e.coli-organismer som uttrycker kolonisationfaktorantigen (cfa) foer vaccinering mot tarminflammation/diarre foerorsakad av enterotoxigeniska e.coli bakterier i maenniskan
Germanier Immunity in experimental salmonellosis III. Comparative immunization with viable and heat-inactivated cells of Salmonella typhimurium
EP0018154B1 (en) Vibrio cholerae mutants, vaccine comprising them, method for preparing a subunit therefrom and composition comprising it
RU93053899A (ru) Способ получения композиции вакцины, способ профилактики кишечных инфекций
US3855408A (en) Poultry vaccine
Matsumoto et al. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice
Bratthall et al. Antigenic variation of Streptococcus mutans colonizing gnotobiotic rats
US20040037851A1 (en) Fusobacterium necrophorum vaccine and method for making such vaccine
KANEMORI et al. The role of extracellular protease produced by Vibrio anguillarum
Yamaguchi et al. Antibody formation against Salmonella flagella by an immune ribonucleic acid fraction
Boesman-Finkelstein et al. Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine
Fierer et al. Active immunization with LD842, a plasmid-cured strain of Salmonella dublin, protects mice against group D and group B Salmonella infection
EP0686039B1 (en) Method of enhancing immune response to oral vaccines
US3885011A (en) Vaccine adjuvants
Lahir et al. Biological similarity of enterotoxins of Vibrio cholerae serotypes other than type 1 to cholera toxin and Escherichia coli heat-labile enterotoxin
Rodgers et al. Oral immunisation against furunculosis: an evaluation of two field trials
Longfellow et al. Typhoid Vaccine Studies VII: Typhoid-Paratyphoid Vaccine
Homma et al. Effectiveness of immunization with multicomponent vaccines in protection against hemorrhagic pneumonia due to Pseudomonas aeruginosa infection in mink
Davis et al. Further observations on the use of a bivalent bacterin against Haemophilus gallinarum
RU2190424C1 (ru) Антигенный состав чумной химической вакцины
IE54590B1 (en) Detoxified e. coli neurotoxin, preparation thereof and immunological preparations containing it
Chander et al. A note: polyvalent radiovaccine against Salmonella
Holder et al. Oral Pseudomonas aeruginosa immunization enhances survival in mice subsequently burned and infected with P. aeruginosa
EP1200121A2 (en) Fish vaccine
Schultz The Bacteriophage: Its Prophylactic and Therapeutic Value: A Review